NCT03194815 IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03130517 Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease Status UNKNOWN Phase EARLY_PHASE1
NCT03018652 Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1 Status COMPLETED Phase PHASE2
NCT02697292 IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy Status TERMINATED Phase PHASE3
NCT02637700 Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy Status COMPLETED Phase PHASE2
NCT02586051 A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation Status COMPLETED Phase PHASE1
NCT02414490 IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Status COMPLETED Phase N/A
NCT02398994 A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis Status TERMINATED Phase PHASE3
NCT02205762 LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT01696500 Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. Status COMPLETED Phase PHASE3
NCT01594424 A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT01561755 A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy Status TERMINATED Phase PHASE4
NCT00850005 Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain Status UNKNOWN Phase PHASE2
NCT00722475 Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage Status COMPLETED Phase PHASE3
NCT00615797 Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea Status COMPLETED Phase NA
NCT00511212 Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract Status WITHDRAWN Phase NA
NCT00483119 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus Status TERMINATED Phase PHASE2
NCT00299988 Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease Status TERMINATED Phase PHASE2